Top Story

In type 2 diabetes, 6-month regimen of metformin improved body composition

September 1, 2014

In adult patients recently diagnosed with type 2 diabetes, a 6-month regimen of metformin appears to have positive effects on body composition, insulin sensitivity and glucose homeostasis, according to recent findings.

In the prospective, non-interventional, observational study, researchers evaluated 51 patients (mean age, 52.67 years) recently diagnosed with type 2 diabetes and started on a metformin regimen. The regimen consisted of 1000 mg metformin, twice daily for 6 months. The researchers evaluated changes in body composition, insulin resistance, insulin sensitivity and metabolic control induced by metformin.

Obesity Action Coalition calls for action against online apps fostering weight bias, shame

August 31, 2014
The Obesity Action Coalition and other supporting organizations have called on, Apple Inc., Google Inc. and the Microsoft Corporation to remove online…

Nonprofit publishes first quality report as part of CMS' QEC program

August 30, 2014
CMS and the Oregon Health Care Quality Corporation announced the publication of the first public report of provider performance using data from the CMS’ Qualified…
In the Journals

Early weight regain after Roux-en-Y did not affect insulin sensitivity, but ghrelin could be predictor

August 29, 2014
Weight regain in the couple years following Roux-en-Y gastric bypass does not reverse improvements in insulin sensitivity, according to research published…
More News Headlines »

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video

Video: Ardis Hoven, MD, explains which changes to the ACA will help physicians most

August 8, 2014
After speaking in an expert panel at the American Association of Diabetes Educators Annual Meeting, Ardis Hoven
More »

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »